» Articles » PMID: 37720874

Comorbidity of Pulmonary Fibrosis and COPD/Emphysema: Research Status, Trends, and Future Directions --------- A Bibliometric Analysis from 2004 to 2023

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The comorbidity of pulmonary fibrosis and COPD/emphysema has garnered increasing attention. However, no bibliometric analysis of this comorbidity has been conducted thus far. This study aims to perform a bibliometric analysis to explore the current status and cutting-edge trends in the field, and to establish new directions for future research.

Methods: Statistical computing, graphics, and data visualization tools such as VOSviewer, CiteSpace, Biblimatrix, and WPS Office were employed.

Results: We identified a total of 1827 original articles and reviews on the comorbidity of pulmonary fibrosis and COPD/emphysema published between 2004 and 2023. There was an observed increasing trend in publications related to this comorbidity. The United States, Japan, and the United Kingdom were the countries with the highest contributions. Professor Athol Wells and the University of Groningen had the highest h-index and the most articles, respectively. Through cluster analysis of co-cited documents, we identified the top 17 major clusters. Keyword analysis predicted that NF-κB, oxidative stress, physical activity, and air pollution might be hot spots in this field in the future.

Conclusion: This bibliometric analysis demonstrates a continuous increasing trend in literature related to the comorbidity of pulmonary fibrosis and COPD/emphysema. The research hotspots and trends identified in this study provide a reference for in-depth research in this field, aiming to promote the development of the comorbidity of pulmonary fibrosis and COPD/emphysema.

Citing Articles

Research Status and Direction of Chronic Obstructive Pulmonary Disease Complicated with Coronary Heart Disease: A Bibliometric Analysis from 2005 to 2024.

Bian H, Zhu S, Xing W, Qi L, Xue J, Peng X Int J Chron Obstruct Pulmon Dis. 2025; 20():23-41.

PMID: 39802036 PMC: 11724669. DOI: 10.2147/COPD.S495326.


Artificial Intelligence in Chronic Obstructive Pulmonary Disease: Research Status, Trends, and Future Directions --A Bibliometric Analysis from 2009 to 2023.

Bian H, Zhu S, Zhang Y, Fei Q, Peng X, Jin Z Int J Chron Obstruct Pulmon Dis. 2024; 19:1849-1864.

PMID: 39185394 PMC: 11345018. DOI: 10.2147/COPD.S474402.

References
1.
Parker M, Rossi D, Peterson M, Smith K, Sikstrom K, White E . Fibrotic extracellular matrix activates a profibrotic positive feedback loop. J Clin Invest. 2014; 124(4):1622-35. PMC: 3971953. DOI: 10.1172/JCI71386. View

2.
Baarsma H, Konigshoff M . : WNT signalling in chronic lung diseases. Thorax. 2017; 72(8):746-759. PMC: 5537530. DOI: 10.1136/thoraxjnl-2016-209753. View

3.
Schafer M, White T, Iijima K, Haak A, Ligresti G, Atkinson E . Cellular senescence mediates fibrotic pulmonary disease. Nat Commun. 2017; 8:14532. PMC: 5331226. DOI: 10.1038/ncomms14532. View

4.
Christie J, Shah C, Kawut S, Mangalmurti N, Lederer D, Sonett J . Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Am J Respir Crit Care Med. 2009; 180(10):1010-5. PMC: 2778153. DOI: 10.1164/rccm.200901-0118OC. View

5.
Rabe K, Watz H . Chronic obstructive pulmonary disease. Lancet. 2017; 389(10082):1931-1940. DOI: 10.1016/S0140-6736(17)31222-9. View